Abbisko Cayman Limited (HKG:2256)
Hong Kong
· Delayed Price · Currency is HKD 7.87
-0.19 (-2.36%)
May 14, 2025, 11:44 AM HKT
Abbisko Cayman Market Cap
Abbisko Cayman has a market cap or net worth of 5.04 billion as of May 13, 2025. Its market cap has increased by 148.30% in one year.
Market Cap
5.04B
Enterprise Value
2.92B
Revenue
536.33M
Ranking
n/a
PE Ratio
189.35
Stock Price
7.87
Market Cap Chart
Since October 15, 2021, Abbisko Cayman's market cap has decreased from 8.71B to 5.04B, a decrease of -42.20%. That is a compound annual growth rate of -14.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 13, 2025 | 5.04B | 75.06% |
| Dec 31, 2024 | 2.88B | 21.63% |
| Dec 29, 2023 | 2.36B | 4.97% |
| Dec 30, 2022 | 2.25B | -64.77% |
| Dec 31, 2021 | 6.39B | -26.60% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeiGene | 196.20B |
| Hansoh Pharmaceutical Group Company | 130.51B |
| JD Health International | 121.51B |
| WuXi Biologics | 94.43B |
| Alibaba Health Information Technology | 84.76B |
| Innovent Biologics | 81.49B |
| Akeso | 71.36B |
| Sino Biopharmaceutical | 68.71B |